Rheumatoid arthritis

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis

RMD OpenPublished Systematic review and individual participant data meta-analysis of randomised trials

Pooled result · Change in lumbar spine BMDResult — go to the resultDifference −0.021 g/cm² 95% CI −0.037 to −0.005

Authors' conclusion

Low-dose GCs, used for 2 years to treat RA, lead to bone loss at the lumbar spine but not at the femur.

Study context

Population
Patients with early and established rheumatoid arthritis (RA) in randomised trials5 of 6 identified trials
Participants
1,112 patients
Comparison
Low-dose glucocorticoid (GCs) (≤7.5 mg prednisone equivalent/day) vs placebo or standard of care, with background DMARDs allowed
Outcome
Co-primary: changes in lumbar spine and femoral BMD and participants with ≥1 clinical fracture (ITT)
Follow-up
2 years
Methodological detailsprotocolised, one-stage models, multiple imputation, intention-to-treat, Sensitivity analyses yielded consistent results
  • Protocolised
  • One-stage models
  • Multiple imputation
  • Intention-to-treat
  • Sensitivity analyses yielded consistent results

Pooled result

Change in lumbar spine BMD

Difference

−0.021 g/cm²

95% CI −0.037 to −0.005

P = 0.034

GCvs Control
difference −0.021 g/cm² (95% CI −0.037 to −0.005); P = 0.034

As reported in the abstract

Further pooled results

OutcomeDifference (g/cm²) (95% CI)P value
Co-primary: change in femoral BMD · 2 yearsI²=0% · intention-to-treat0.004 (−0.008 to 0.016)P = 0.47

Co-primary: participants with ≥1 clinical fracture · 2 years

Participants with ≥1 fracture (total)
35
Fracture risk comparable in both groups

Original publication

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis. RMD Open. Published 7 May 2026. doi:10.1136/rmdopen-2025-006615

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.